Lanlan Zhou
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 23
- Cancer-related Molecular Pathways 6
- Cancer Immunotherapy and Biomarkers 5
- Colorectal Cancer Treatments and Studies 4
-
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Wafik S. El‐Deiry (43 shared papers)Cristina I. Truica (2 shared papers)Joseph J. Drabick (2 shared papers)Yuchao Chen (1 shared paper)Po‐Hsun Huang (1 shared paper)Peng Li (1 shared paper)Zhangli Peng (1 shared paper)Ming Dao (1 shared paper)
- Journals
- Oncotarget (7 papers)Cancer Biology & Therapy (6 papers)Cell Cycle (5 papers)Frontiers in Pharmacology (4 papers)Frontiers in Oncology (2 papers)
- Partner nations
- United StatesChinaIndia
In The Last Decade
Lanlan Zhou
65 papers receiving 2.4k citations
Lanlan Zhou's Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 267
- Oncology 417
- Biomedical Engineering 657
- Genetics 141
- Molecular Biology 644
Countries citing papers authored by Lanlan Zhou
This map shows the geographic impact of Lanlan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Zhou more than expected).
Fields of papers citing papers by Lanlan Zhou
This network shows the impact of papers produced by Lanlan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Zhou. The network helps show where Lanlan Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Lanlan Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Acoustic separation of circulating tumor cells Hit paper breakdown → | 2015 | 688 |
| 2 | 2020 | 139 | |
| 3 | 2016 | 137 | |
| 4 | 2021 | 120 | |
| 5 | 2015 | 95 | |
| 6 | 2017 | 69 | |
| 7 | 2018 | 65 | |
| 8 | 2016 | 64 | |
| 9 | 2020 | 58 | |
| 10 | 2009 | 50 | |
| 11 | 2009 | 46 | |
| 12 | 2004 | 45 | |
| 13 | 2017 | 42 | |
| 14 | 2020 | 40 | |
| 15 | 2017 | 39 | |
| 16 | 2021 | 39 | |
| 17 | 2017 | 37 | |
| 18 | 2018 | 36 | |
| 19 | 2021 | 34 | |
| 20 | 2021 | 34 |
About Lanlan Zhou
Lanlan Zhou is a scholar working on Oncology, Cancer Research, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 67 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (11 papers), Optical Imaging and Spectroscopy Techniques (7 papers), Cancer-related Molecular Pathways (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Protein Degradation and Inhibitors (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Cancer Research (267 citations), Oncology (417 citations), Biomedical Engineering (657 citations), Genetics (141 citations) and Molecular Biology (644 citations). Lanlan Zhou has collaborated with scholars based in United States, China and India. Frequent co-authors include Wafik S. El‐Deiry, Cristina I. Truica, Joseph J. Drabick, Yuchao Chen, Po‐Hsun Huang, Peng Li, Zhangli Peng, Ming Dao, Tony Jun Huang and Zhangming Mao. Their work appears in journals such as Oncotarget, Cancer Biology & Therapy, Cell Cycle, Frontiers in Pharmacology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.